Cargando…
Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells
BACKGROUND: Rhabdomyosarcoma (RMS) is a highly malignant pediatric cancer that is the most common form of soft tissue tumors in children. RMS cells have many features of skeletal muscle cells, yet do not differentiate. Thus, our studies have focused on the defects present in these cells that block m...
Autores principales: | Zhang, Meiling, Truscott, Jamie, Davie, Judith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879063/ https://www.ncbi.nlm.nih.gov/pubmed/24279793 http://dx.doi.org/10.1186/1476-4598-12-150 |
Ejemplares similares
-
TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle
por: Zhu, Bo, et al.
Publicado: (2015) -
Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma
por: Pomella, Silvia, et al.
Publicado: (2021) -
Twist2 amplification in rhabdomyosarcoma represses myogenesis and promotes oncogenesis by redirecting MyoD DNA binding
por: Li, Stephen, et al.
Publicado: (2019) -
MEF2C loss-of-function mutation contributes to congenital heart defects
por: Qiao, Xiao-Hui, et al.
Publicado: (2017) -
MEF2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury
por: Xia, Xin, et al.
Publicado: (2020)